Click it and Unblock the Notifications
Latest Updates
-
Purported Video of Muslim Mob Lynching & Hanging Hindu Youth In Bangladesh Shocks Internet -
A Hotel on Wheels: Bihar Rolls Out Its First Luxury Caravan Buses -
Bharti Singh-Haarsh Limbachiyaa Welcome Second Child, Gender: Couple Welcome Their Second Baby, Duo Overjoyed - Report | Bharti Singh Gives Birth To Second Baby Boy | Gender Of Bharti Singh Haarsh Limbachiyaa Second Baby -
Bharti Singh Welcomes Second Son: Joyous News for the Comedian and Her Family -
Gold & Silver Rates Today in India: 22K, 24K, 18K & MCX Prices Fall After Continuous Rally; Check Latest Gold Rates in Chennai, Mumbai, Bangalore, Hyderabad, Ahmedabad & Other Cities on 19 December -
Nick Jonas Dancing to Dhurandhar’s “Shararat” Song Goes Viral -
From Consciousness To Cosmos: Understanding Reality Through The Vedic Lens -
The Sunscreen Confusion: Expert Explains How to Choose What Actually Works in Indian Weather -
On Goa Liberation Day 2025, A Look At How Freedom Shaped Goa Into A Celebrity-Favourite Retreat -
Daily Horoscope, Dec 19, 2025: Libra to Pisces; Astrological Prediction for all Zodiac Signs
COVID-19 Vaccine: Government Panel Recommends EUA For Corbevax For Kids Between 5-11 Years Age Groups
An expert panel of India's central drug authority has recommended granting emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for children in the five to 11 years age group, official sources said on Thursday.
The Subject Expert Committee on COVID-19 of the CDSCO has, however, sought more data from Bharat Biotech to review its emergency use authorisation (EUA) application for use of Covaxin among those aged between two and 11 years, they said.
The Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on 28 December last year and in the 12 to 17 years age group, subject to certain conditions, on 9 March this year.
Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years. Covaxin has been granted Emergency Use Listing (EUL) by the DCGI for the age group of 12 to 18 years on 24 December 2021.
"The Subject Expert Committee on COVID-19 of the CDSCO which deliberated on Biological E's EUA application has recommended granting emergency use authorisation for use of Corbevax in the age group of five to 11 years," a source said.
India
began
inoculating
children
aged
12-14
on
16
March.
The
countrywide
vaccination
drive
was
rolled
out
on
16
January
last
year
with
healthcare
workers
getting
inoculated
in
the
first
phase.
Vaccination
of
frontline
workers
started
on
2
February
last
year.
The next phase of COVID-19 vaccination commenced on 1 March last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.
India launched vaccination for all people aged more than 45 years on 1 April last year. The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from 1 May last year.
The next phase of vaccination commenced on 3 January for adolescents in the age group of 15-18 years.
India began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities on 10 January.
Precaution dose of COVID-19 vaccines to all aged above 18 years was allowed at private vaccination centres from 10 April.
Continue with Google